Dr. Paul Klotman began serving as president, CEO and executive dean of Baylor College of Medicine on September 1, 2010. He received his B.S. degree in 1972 from the University of Michigan and his M.D. from Indiana University in 1976. He completed his medicine and nephrology training at Duke University Medical Center. He stayed at Duke as a faculty member before moving to the National Institutes of Health (NIH) in 1988, where he became chief of the Molecular Medicine Section in the Laboratory of Developmental Biology. In 1993, he became the chief of the Viral Pathogenesis Laboratory at the National Institute of Dental and Craniofacial Research of the NIH. In 1994, he moved to Mount Sinai School of Medicine as chief of the Division of Nephrology. In 2001, he was appointed to the chair of the Samuel Bronfman Department of Medicine of the Mount Sinai School of Medicine.
At Baylor, he oversees the only private health sciences university in the Southwestern United States, with total research funding of more than $650 million. The School of Health Professions is among the best in the nation as is the Graduate School of Biomedical Sciences. The College is also home to the first National School of Tropical Medicine in North America. Baylor is ranked first among all Texas colleges, universities and medical schools in federal funding for research and development, and it is ranked second in federally funded research expenditures by the National Science Foundation.
As the CEO of Baylor College of Medicine, Dr. Klotman oversees approximately 15,000 employees, 3,500 students, residents and fellows. He is responsible for the Baylor medical staff at Baylor St. Luke’s Medical Center, Texas Children’s Hospital, the Michael E. DeBakey Veterans Affairs Medical Center, Ben Taub Hospital and its affiliated clinics, the Menninger Clinic and the Children’s Hospital of San Antonio. He serves on the Board of Directors of St. Luke’s Health System and the Baylor St. Luke’s Medical Center, the College’s jointly owned and governed private adult hospital. The enterprise revenue is over $2.3 billion with net assets of approximately $2.5 billion.
